Andrew Lo - Net Worth and Insider Trading
Andrew Lo Net Worth
The estimated net worth of Andrew Lo is at least $1.5 Billion dollars as of 2024-11-13. Andrew Lo is the 10% Owner of Myovant Sciences Ltd and owns about 40,765,599 shares of Myovant Sciences Ltd (MYOV) stock worth over $1.1 Billion. Andrew Lo is the 10% Owner of Urovant Sciences Ltd and owns about 22,860,013 shares of Urovant Sciences Ltd (UROV) stock worth over $371 Million. Andrew Lo is also the 10% Owner of Sio Gene Therapies Inc and owns about 13,244,048 shares of Sio Gene Therapies Inc (SIOX) stock worth over $6 Million. Besides these, Andrew Lo also holds BridgeBio Pharma Inc (BBIO) , AbCellera Biologics Inc (ABCL) . Details can be seen in Andrew Lo's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Lo has not made any transactions after 2021-12-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Lo
Andrew Lo Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Lo owns 7 companies in total, including BridgeBio Pharma Inc (BBIO) , Arbutus Biopharma Corp (ABUS) , and Sio Gene Therapies Inc (SIOX) among others .
Click here to see the complete history of Andrew Lo’s form 4 insider trades.
Insider Ownership Summary of Andrew Lo
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BBIO | BridgeBio Pharma Inc | 2021-12-30 | director |
| ABUS | Arbutus Biopharma Corp | 2016-07-08 | 10 percent owner |
| SIOX | Sio Gene Therapies Inc | 2019-03-18 | 10 percent owner |
 | | 2019-06-04 | 10 percent owner |
| | 2019-07-10 | other: Former 10% Owner |
| | 2021-10-01 | director |
| | 2021-12-03 | director |
Andrew Lo Latest Holdings Summary
Andrew Lo currently owns a total of 5 stocks. Among these stocks, Andrew Lo owns 40,765,599 shares of Myovant Sciences Ltd (MYOV) as of June 4, 2019, with a value of $1.1 Billion and a weighting of 74.12%. Andrew Lo owns 22,860,013 shares of Urovant Sciences Ltd (UROV) as of June 19, 2019, with a value of $371 Million and a weighting of 25.02%. Andrew Lo also owns 13,244,048 shares of Sio Gene Therapies Inc (SIOX) as of March 18, 2019, with a value of $6 Million and a weighting of 0.43%. The other 2 stocks BridgeBio Pharma Inc (BBIO) , AbCellera Biologics Inc (ABCL) have a combined weighting of 0.44% among all his current holdings.
Latest Holdings of Andrew Lo
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MYOV | Myovant Sciences Ltd | 2019-06-04 | 40,765,599 | 26.98 | 1,099,855,861 |
| UROV | Urovant Sciences Ltd | 2019-06-19 | 22,860,013 | 16.24 | 371,246,611 |
| SIOX | Sio Gene Therapies Inc | 2019-03-18 | 13,244,048 | 0.48 | 6,330,655 |
| BBIO | BridgeBio Pharma Inc | 2021-12-30 | 253,682 | 24.62 | 6,245,651 |
| ABCL | AbCellera Biologics Inc | 2021-12-03 | 86,938 | 2.95 | 256,467 |
Holding Weightings of Andrew Lo
Andrew Lo Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Lo has made a total of 0 transactions in Myovant Sciences Ltd (MYOV) over the past 5 years. The most-recent trade in Myovant Sciences Ltd is the acquisition of 2,424,242 shares on June 4, 2019, which cost Andrew Lo around $20 Million.
According to the SEC Form 4 filings, Andrew Lo has made a total of 0 transactions in Urovant Sciences Ltd (UROV) over the past 5 years. The most-recent trade in Urovant Sciences Ltd is the acquisition of 18,204 shares on June 19, 2019, which cost Andrew Lo around $151,457.
According to the SEC Form 4 filings, Andrew Lo has made a total of 0 transactions in Sio Gene Therapies Inc (SIOX) over the past 5 years. The most-recent trade in Sio Gene Therapies Inc is the acquisition of 833,333 shares on March 18, 2019, which cost Andrew Lo around $10 Million.
More details on Andrew Lo's insider transactions can be found in the Insider Trading History of Andrew Lo table.Insider Trading History of Andrew Lo
- 1
Andrew Lo Trading Performance
GuruFocus tracks the stock performance after each of Andrew Lo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Lo is 0.79%. GuruFocus also compares Andrew Lo's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Lo within 3 months outperforms 9 times out of 16 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew Lo's insider trading performs compared to the benchmark.
Performance of Andrew Lo
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.16 | | | | | |
| Relative Return to S&P 500(%) | -3.08 | | | | | |
Andrew Lo Ownership Network
Ownership Network List of Andrew Lo
Ownership Network Relation of Andrew Lo
Andrew Lo Owned Company Details
What does BridgeBio Pharma Inc do?
Who are the key executives at BridgeBio Pharma Inc?
Andrew Lo is the director of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include 10 percent owner Kkr Genetic Disorder L.p. , director & See Remarks Neil Kumar , and See Remarks Brian C Stephenson .
BridgeBio Pharma Inc (BBIO) Insider Trades Summary
Over the past 18 months, Andrew Lo made no insider transaction in BridgeBio Pharma Inc (BBIO). Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 12,000 shares made by Randal W Scott , a net sale of 182,045 shares made by Neil Kumar , and a net sale of 73,947 shares made by Brian C Stephenson .
In summary, during the past 3 months, insiders sold 5,831,544 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 5,831,544 shares. During the past 18 months, 7,676,737 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,676,737 shares.
BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
BridgeBio Pharma Inc Insider Transactions
Andrew Lo Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Lo. You might contact Andrew Lo via mailing address: C/o Alphasimplex Group, Llc, One Cambridge Center, 9th Floor, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
